Doximity, Inc. Class A Common Stock (DOCS)
69.51
0.00 (0.00%)
Doximity Inc is a digital platform designed specifically for medical professionals, primarily physicians, to enhance communication and collaboration within the healthcare community
The platform provides a range of tools and resources, including secure messaging, telehealth services, and access to a network of healthcare professionals, allowing doctors to connect with each other and stay updated on medical news and developments. Additionally, Doximity offers features such as electronic faxing, a comprehensive directory of healthcare providers, and opportunities for continuing medical education, all aimed at improving clinical workflows and ultimately enhancing patient care.

Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Doximity, Inc. (“Doximity”) (NYSEDOCS) breached their fiduciary duties to Doximity and its shareholders.
By Scott+Scott Attorneys at Law LLP · Via Business Wire · February 21, 2025

Doximity, Inc. (NYSEDOCS), the leading digital platform for U.S. medical professionals, today announced that Anna Bryson, CFO, will present at the Raymond James 46th Annual Institutional Investors Conference on Tuesday, March 4, 2025, at 10:25 a.m. Eastern Time/7:25 a.m. Pacific Time.
By Doximity · Via Business Wire · February 13, 2025

Doximity, Inc. (NYSEDOCS), the leading digital platform for U.S. medical professionals, announced today that Doximity Dialer has been named 2025 Best in KLAS in the Video Conferencing Platforms segment. This is the fourth consecutive year that Doximity has earned the top position.
By Doximity · Via Business Wire · February 6, 2025

Doximity, Inc. (NYSEDOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 third quarter ended December 31, 2024.
By Doximity · Via Business Wire · February 6, 2025

Doximity, Inc. (NYSEDOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2024 after market close on February 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.
By Doximity · Via Business Wire · January 16, 2025

NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Doximity, Inc. (NYSEDOCS) on behalf of long-term stockholders following a class action complaint that was filed against Doximity on April 17, 2024 with a Class Period from February 9, 2022, to April 1, 2024. Our investigation concerns whether the board of directors of Doximity have breached their fiduciary duties to the company.
By Bragar Eagel & Squire · Via GlobeNewswire · December 19, 2024

Doximity, Inc. (NYSEDOCS), the leading digital platform for U.S. medical professionals, today released its State of Telemedicine Report, showing that 83% of physician telemedicine users surveyed would like virtual care to remain a permanent part of their clinical practice. Among physicians surveyed, 84% highlighted telemedicine’s value in improving continuity of care for patients with chronic or complex conditions, and 96% emphasized its role as a complement to or, depending on the patient, a replacement for in-person care.
By Doximity · Via Business Wire · December 17, 2024

Doximity, Inc. (NYSEDOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 second quarter ended September 30, 2024.
By Doximity · Via Business Wire · November 7, 2024

Doximity, Inc. (NYSEDOCS), the leading digital platform for U.S. medical professionals, today announced that Nate Gross, co-founder and chief strategy officer, and Anna Bryson, chief financial officer, will present at the Jefferies London Healthcare Conference on Thursday, November 21, 2024 at 11:30 a.m. GMT/6:30 a.m. ET.
By Doximity · Via Business Wire · October 31, 2024

Doximity, Inc. (NYSEDOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ended September 30, 2024 after market close on November 7, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.
By Doximity · Via Business Wire · October 17, 2024

Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Doximity, Inc. (“Doximity”) (NYSEDOCS) breached their fiduciary duties to Doximity and its shareholders.
By Scott+Scott Attorneys at Law LLP · Via Business Wire · October 7, 2024

NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Doximity, Inc. (NYSEDOCS) on behalf of long-term stockholders following a class action complaint that was filed against Doximity on April 17, 2024 with a Class Period from February 9, 2022, to April 1, 2024. Our investigation concerns whether the board of directors of Doximity have breached their fiduciary duties to the company.
By Bragar Eagel & Squire · Via GlobeNewswire · September 25, 2024

Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Doximity, Inc. (“Doximity”) (NYSEDOCS) breached their fiduciary duties to Doximity and its shareholders.
By Scott+Scott Attorneys at Law LLP · Via Business Wire · September 23, 2024

NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Doximity, Inc. (NYSEDOCS) on behalf of long-term stockholders following a class action complaint that was filed against Doximity on April 17, 2024 with a Class Period from February 9, 2022, to April 1, 2024. Our investigation concerns whether the board of directors of Doximity have breached their fiduciary duties to the company.
By Bragar Eagel & Squire · Via GlobeNewswire · September 16, 2024

Doximity Inc. (NYSEDOCS) is a digital professional medical networking platform that is a cross between LinkedIn and Meta Platforms Inc.
Via MarketBeat · August 21, 2024

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (NYSEDOCS).
By Kahn Swick & Foti, LLC · Via Business Wire · August 16, 2024

Doximity, Inc. (NYSEDOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 first quarter ended June 30, 2024.
By Doximity · Via Business Wire · August 8, 2024

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (NYSEDOCS).
By Kahn Swick & Foti, LLC · Via Business Wire · July 19, 2024

Doximity, Inc. (NYSEDOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.
By Doximity · Via Business Wire · July 18, 2024

NEW YORK, June 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Doximity, Inc. (NYSEDOCS) on behalf of long-term stockholders following a class action complaint that was filed against Doximity on April 17, 2024 with a Class Period from February 9, 2022 to April 1, 2024. Our investigation concerns whether the board of directors of Doximity have breached their fiduciary duties to the company.
By Bragar Eagel & Squire · Via GlobeNewswire · June 19, 2024

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. (“Doximity” or “the Company”) (NYSEDOCS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By The Schall Law Firm · Via Business Wire · June 17, 2024

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against Doximity, Inc. (NYSEDOCS), if they purchased or otherwise acquired the Company’s shares between February 9, 2022, and April 1, 2024, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District California.
By Kahn Swick & Foti, LLC · Via Business Wire · June 14, 2024

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. (“Doximity” or “the Company”) (NYSEDOCS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By The Schall Law Firm · Via Business Wire · June 14, 2024

The Law Offices of Frank R. Cruz reminds investors of the upcoming June 17, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Doximity, Inc. (“Doximity” or the “Company”) (NYSEDOCS) common stock between February 9, 2022, and April 1, 2024, inclusive (the “Class Period”).
By The Law Offices of Frank R. Cruz · Via Business Wire · June 14, 2024

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Doximity, Inc. (“Doximity” or “the Company”) (NYSEDOCS) for violations of the securities laws.
By The Schall Law Firm · Via Business Wire · June 13, 2024